First-line treatment of mCapOX plus cetuximab versus mFOLFOX6 plus cetuximab for metastatic left-sided CRC patients with wild-type RAS/BRAF genes: a multicenter, randomised, phase 2 study
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2707319
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Experimental groupA:mCapOX+ Cetuximab;Experimental groupB:mFOLFOX6+ Cetuximab
Primary outcome(s): Progression free survival;Progression free survival
Study Design: Parallel
创建时间：
2021-07-15
